Tuberculosis, HIV and TB/HIV co-infection in the Prison System of Itirapina, São Paulo, Brazil
PDF (Português (Brasil))

Keywords

prevalence
HIV
tuberculosis
prisons
co-infection TB/HIV

How to Cite

1.
Aily DCG, Berra JAP, Brandão AP, Chimara E. Tuberculosis, HIV and TB/HIV co-infection in the Prison System of Itirapina, São Paulo, Brazil. Rev Inst Adolfo Lutz [Internet]. 2013 Apr. 25 [cited 2024 Jul. 22];72(4):288-94. Available from: https://periodicos.saude.sp.gov.br/RIAL/article/view/32930

Abstract

HIV, tuberculosis (TB) and TB/HIV co-infection prevalences were assessed in prisons PI and PII in Itirapina, SP, Brazil. This retrospective study was performed by consulting the records of diagnostic assays carried out at the Instituto Adolfo Lutz (IAL) Rio Claro Laboratory from January 2003 to December 2010. Culture for TB was performed on 24.3 % (1,375 samples) of PI and 25.8 % (3,332 samples) of PII, and HIV serology in 32.0 % (1,810 samples) of PI and 20.4 % (2,634 samples) of PII. There were 177 (4.0 %) HIV positive samples, 157 (3.3 %) positive culture for mycobacteria, and 16 (11.5 %) for TB/HIV. The prevalences of TB were 2.8 % and 3.6 % (p=0.160) for PI and PII respectively; of HIV, 2.1 % and 5.3 % (p<0.001) for PI and PII; and of TB/HIV co-infection, 0.4 % (p=0.744) for both PI and PII. Among TB patients, HIV prevalence was 13.2 % in PI and 9.2 % (p=0.487) in PII. Higher HIV prevalence in PII suggests that it depends on the population characteristics. The high prevalence rates of TB, HIV and TB/HIV show that it is crucial to perform the diagnostic testing in all of imprisoned individuals at admission to define the disease treatment and prevention measures among inmates and their contacts.
https://doi.org/10.18241/0073-98552013721576
PDF (Português (Brasil))

References

1. Nogueira PA, Abrahão RMC. A infecção tuberculosa e o tempo de prisão da população carcerária dos Distritos Policiais da zona oeste da cidade de São Paulo. Rev Bras Epidemiol. 2009;12:30-8.

2. Sanchez AR, Massari V, Gerhardt G, Barreto AW, Cesconi V, Pires J, et al. A tuberculose nas prisões do Rio de Janeiro, Brasil: uma urgência de saúde pública. Cad Saúde Pública. 2007;23:545-52.

3. Catalan-Soares BC, Almeida RT, Carneiro-Proietti BF. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B vírus (HBV), hepatitis C vírus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuaçú, Minas Gerais, Brazil. Rev Soc Bras Med Trop. 2000;33:27-30.

4. Nogueira PA, Abrahão RMCM, Galesi VMN. Tuberculosis and latent tuberculosis in prison inmates. Rev Saude Publica. 2012;46:119-27.

5. Cardoso JrR. Prevalência do HIV nos presídios. (acesso 2005 Abr 12). Disponível em :[http://www.aids.gov.br].

6. Winetsky DE, Negoescu DM, DeMarchis EH, Almukhamedova O, Dooronbekova A, Pulatov D, et al. Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLOS Medicine. 2012;9:11.

7. Todrys KW, Amon JJ. Criminal justice reform as HIV and TB prevention in African prisons. PLOS Medicine. 2012;9:5.

8. Yanjindulam P, Oyuntsetseg P, Sarantsetseg B, Ganzaya S, Amgalan S, Narantuya J, et al. Reduction of tuberculosis burden among prisoners in Mongolia: review of case notification, 2001-2010. Int J Tuberc Lung Dis. 2012;16:327-29.

9. Secretaria da Administração Penitenciaria do Estado de São Paulo (SAP). SAP amplia número de vagas com plano de expansão. (acesso 2012 Out 05). Disponível em: [http://www.sap.sp.gov.br/noticias/not147.html].

10. World Health Organization- WHO. Global tuberculosis report 2012. Geneva, Switzerland: WHO; 2012. Disponível em: [http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf].

11. Benito N, Moreno A, Miro JM, Torres A. Pulmonary infections in HIV-infected patients: an update in the 21st century. Eur Respir J. 2012;39:730-45.

12. Kuhleis D, Ribeiro AW, Costa ERD, Cafrune PI, Schmid KB, Costa LL, et al. Tuberculosis in a southern Brazilian prison. Mem Inst Oswaldo Cruz. 2012;107:909-15.

13. Lemos ACM. Coinfecção tuberculose/HIV. J Bras Pneumol. 2008;34:753-5.

14. Jamal LF, Moherdaui F. Tuberculose e infecção pelo HIV no Brasil: magnitude do problema e estratégias para o controle. Rev Saúde Pública. 2007;41:104 -10.

15. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual Nacional de Vigilância Laboratorial da tuberculose e outras micobactérias. Brasília (DF); 2008.

16. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST/AIDS. Recomendações para terapia antirretroviral em adultos e adolescentes infectados pelo HIV 2007/2008. (acesso 2008 Set 21). Disponível em: [http://www.aids.gov.br].

17. Massad E, Rozman M, Azevedo RS, Silveira ASB, Takey K, Yamamoto YI, et al. Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: Preponderance of parenteral transmission. Eur J Epidemiol. 1999;15:439-45.

18. Chimara E, Ferrazoli L, Ueky SYM, Martins MC, Durham AM, Arbeit RD, et al. Reliable identification of mycobacterial species by PCR-restriction enzyme analysis (PRA)-hsp65 in a reference laboratory and elaboration of a sequence-based extended algorithm of PRA-hsp65 patterns. BMC Microbiol. 2008;2;8:48.

19. Reis CB, Bernardes EB. O que acontece atrás das grades: estratégias de prevenção desenvolvidas nas delegacias civis contra HIV/AIDS e outras doenças sexualmente transmissíveis. Ciênc Saúde Coletiva. 2011;16:3331-8.

20. Berra JAP, Bacetti LB, Buzo A. Soroprevalência de HIV, sífilis, hepatite B e C em mulheres do Centro de Ressocialização Feminino, Rio Claro/SP. Rev Inst Adolfo Lutz. 2006;65:133-6.

21. Passadouro R. Prevalência e fatores de risco das infecções por VHI, hepatite B e C num estabelecimento prisional de Leiria. Acta Med Port. 2004;17:381-4.

22. Marco A, Saíz de la Hoya P, García-Guerrero J, Grupo PREVALHEP. Estudio Multicéntrico de Prevalencia de Infección por el VIH y factores asociados en las prisiones de España. Rev Esp Sanid Penit. 2012;14:19-27.

23. Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, Maggard KR, et al. Tuberculosis and HIV Control in Sub-Saharan African Prisons: “Thinking Outside the Prison Cell”. JID. 2012;205:S265-73.

24. Secretaria de Estado da Saúde de São Paulo. Centro de Vigilância Epidemiológica “Prof. Alexandre Vranjac”. Tuberculose no Estado de São Paulo: indicadores de morbimortalidade e indicadores de desempenho. Bol Epidemiol Paulista. 2006;3:S7-S37.

25. Sanchez AR, Larouzé B, Diuana V. Tuberculosis control in Brazilian prisons: new appoaches to an old problem. Cad Saude Publica. 2010;26:850-1.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2013 Instituto Adolfo Lutz Journal

Downloads

Download data is not yet available.